About IntelliSyn
IntelliSyn is a company based in Montreal (Canada) founded in 2011 was acquired by X-Chem in January 2021.. IntelliSyn operates in a competitive market with competitors including Generate Biomedicines, Sai Life Sciences, Plexium, Acies Bio and Anagenex, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IntelliSyn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IntelliSyn
IntelliSyn has secured backing from 1 investor. Prominent investors backing the company include X-Chem. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecule drug discovery platform is provided to researchers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IntelliSyn
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IntelliSyn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intellisyn Comparisons
Competitors of IntelliSyn
IntelliSyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Generate Biomedicines, Sai Life Sciences, Plexium, Acies Bio and Anagenex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Integrated chemistry service provider
|
|
| domain | founded_year | HQ Location |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| domain | founded_year | HQ Location |
Drug discovery services are manufactured by Anagenex in San Francisco.
|
|
| domain | founded_year | HQ Location |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about IntelliSyn
When was IntelliSyn founded?
IntelliSyn was founded in 2011.
Where is IntelliSyn located?
IntelliSyn is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
What does IntelliSyn do?
IntelliSyn was founded in 2011 in Montreal, Canada, as a contract research organization in the pharmaceutical sector. Services encompass synthetic chemistry, computational modeling, analytical techniques, in vitro assays, and in vivo studies to support drug development. Operations are centered on collaborative research for biotech and pharmaceutical clients, with a focus on efficient discovery processes.
Who are the top competitors of IntelliSyn?
IntelliSyn's top competitors include Generate Biomedicines, Sai Life Sciences and Plexium.
Who are IntelliSyn's investors?
IntelliSyn has 1 investor. Key investors include X-Chem.